Skip to main content

Find Clinical Trials

Home
Conditions
Refractory Myelodysplastic/Myeloproliferative Neoplasm

Clinical trial condition

Refractory Myelodysplastic/Myeloproliferative Neoplasm

Explore clinical trials studying Refractory Myelodysplastic/Myeloproliferative Neoplasm. Study availability and eligibility vary by location and protocol.

3 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Refractory Myelodysplastic/Myeloproliferative Neoplasm trial results

Recruiting

Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia

NCT06523556

Conditions: Atypical Chronic Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +20 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms

NCT05549661

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +18 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm

NCT04140487

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details